Treatment introduction
A. Patients with Parkinson’s Disease:
(a) clinically diagnosed with and confirmed to be the typical
Parkinson's disease
(b) patient without insignificant dementia (MMSE ≧ 24)
(c) the result of patient’s therapeutic response to dopamine
(based on Drug challenge test) shows UPDRS part III score,
the improvement rate is above 30%
(d) patient whose course of disease is more than five years
(e) patient without severe internal medical disease or
tumor.
B. Patients with movement disorders:
(a) Severe dystonia, wryneck, essential tremor, secondary
tremor, and other movement disorders or abnormalities
that cannot be controlled by medicine intake
(b) The possibility of severe internal medical disease or
tumor is excluded
Deep Brain Stimulation is a safe and effective therapeutic
approach because it:
A. reduces the dosage of drugs (↓25%~75%)
B. improves patients’ activities of daily living, decreases the
number of return visit (↓25%)
C. enhances patients’ ability of self-care, cuts down nursing-
home or day-care expenses (↓60%)
D. improves patients’ physical mobility, reduces the demands
for physiotherapy, steps down the frequency of fall, pneumonia,
and hospitalization (↓63%)